当前位置: X-MOL 学术Nat. Rev. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeted therapy: ARIEL3 — broad benefit of PARP inhibitors in ovarian cancer
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2017-10-10 , DOI: 10.1038/nrclinonc.2017.161
David Killock

Targeted therapy: ARIEL3 — broad benefit of PARP inhibitors in ovarian cancer

Nature Reviews Clinical Oncology, Published online: 10 October 2017; doi:10.1038/nrclinonc.2017.161



中文翻译:

靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处

靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处

Nature Reviews Clinical Oncology,在线发布:2017年10月10日;doi:10.1038 / nrclinonc.2017.161

更新日期:2017-10-30
down
wechat
bug